These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 24001086)
1. Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus. Shekh-Ahmad T; Hen N; McDonough JH; Yagen B; Bialer M Epilepsia; 2013 Sep; 54 Suppl 6(Suppl 6):99-102. PubMed ID: 24001086 [TBL] [Abstract][Full Text] [Related]
2. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444 [TBL] [Abstract][Full Text] [Related]
3. The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus. Shekh-Ahmad T; Mawasi H; McDonough JH; Yagen B; Bialer M Epilepsy Behav; 2015 Aug; 49():298-302. PubMed ID: 25979572 [TBL] [Abstract][Full Text] [Related]
4. sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats. Bar-Klein G; Swissa E; Kamintsky L; Shekh-Ahmad T; Saar-Ashkenazy R; Hubary Y; Shrot S; Stetlander L; Eisenkraft A; Friedman A; Bialer M Epilepsia; 2014 Dec; 55(12):1953-8. PubMed ID: 25377630 [TBL] [Abstract][Full Text] [Related]
5. A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus. Pouliot W; Bialer M; Hen N; Shekh-Ahmad T; Kaufmann D; Yagen B; Ricks K; Roach B; Nelson C; Dudek FE Neuroscience; 2013 Feb; 231():145-56. PubMed ID: 23159312 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-Pharmacodynamic Correlation and Brain Penetration of sec-Butylpropylacetamide, a New CNS Drug Possessing Unique Activity against Status Epilepticus. Mawasi H; Bibi D; Shekh-Ahmad T; Shaul C; Blotnik S; Bialer M Mol Pharm; 2016 Jul; 13(7):2492-6. PubMed ID: 27218460 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of valnoctamide and sec-butylpropylacetamide (SPD) in terminating nerve agent-induced seizures in pediatric rats. Haines KM; Matson LM; Dunn EN; Ardinger CE; Lee-Stubbs R; Bibi D; McDonough JH; Bialer M Epilepsia; 2019 Feb; 60(2):315-321. PubMed ID: 30615805 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid. Mawasi H; Shekh-Ahmad T; Finnell RH; Wlodarczyk BJ; Bialer M Epilepsy Behav; 2015 May; 46():72-8. PubMed ID: 25863940 [TBL] [Abstract][Full Text] [Related]
9. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential. Shekh-Ahmad T; Hen N; Yagen B; McDonough JH; Finnell RH; Wlodarczyk BJ; Bialer M Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671 [TBL] [Abstract][Full Text] [Related]
10. Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticus. Hen N; Shekh-Ahmad T; Yagen B; McDonough JH; Finnell RH; Wlodarczyk B; Bialer M J Med Chem; 2013 Aug; 56(16):6467-77. PubMed ID: 23879329 [TBL] [Abstract][Full Text] [Related]
11. Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid. Pessah N; Yagen B; Hen N; Shimshoni JA; Wlodarczyk B; Finnell RH; Bialer M Epilepsy Behav; 2011 Nov; 22(3):461-8. PubMed ID: 21959082 [TBL] [Abstract][Full Text] [Related]
12. Valproic acid derivatives signal for apoptosis and repair in vitro. Neuman MG; Nanau RM; Shekh-Ahmad T; Yagen B; Bialer M Clin Biochem; 2013 Oct; 46(15):1532-7. PubMed ID: 23868021 [TBL] [Abstract][Full Text] [Related]
13. Early polytherapy for benzodiazepine-refractory status epilepticus. Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007 [TBL] [Abstract][Full Text] [Related]
14. The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication. Althaus AL; McCarren HS; Alqazzaz A; Jackson C; McDonough JH; Smith CD; Hoffman E; Hammond RS; Robichaud AJ; Doherty JJ Epilepsy Behav; 2017 Mar; 68():22-30. PubMed ID: 28109985 [TBL] [Abstract][Full Text] [Related]
15. Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model. Leclercq K; Kaminski RM Epilepsy Behav; 2015 Aug; 49():55-60. PubMed ID: 26123104 [TBL] [Abstract][Full Text] [Related]
16. Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats. Mareš P; Kubová H; Hen N; Yagen B; Bialer M Epilepsy Res; 2013 Sep; 106(1-2):64-73. PubMed ID: 23815889 [TBL] [Abstract][Full Text] [Related]
17. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models. Löscher W Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944 [TBL] [Abstract][Full Text] [Related]
18. Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman. Reddy DS; Zaayman M; Kuruba R; Wu X Neuropharmacology; 2021 Jun; 191():108571. PubMed ID: 33878303 [TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of status epilepticus induced by soman]. Blanchet G; Carpentier P; Lallement G; Sentenac-Roumanou H Ann Pharm Fr; 1994; 52(1):11-24. PubMed ID: 8085742 [TBL] [Abstract][Full Text] [Related]
20. Effect of U50488, a selective kappa opioid receptor agonist and levetiracetam against lithium-pilocarpine-induced status epilepticus, spontaneous convulsive seizures and related cognitive impairment. Kumar H; Katyal J; Kumar Gupta Y Neurosci Lett; 2023 Oct; 815():137477. PubMed ID: 37714287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]